Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
Use this PTGX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PTGX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PTGX SEC filings page. Lician reads the product cache first so this HTML stays unique to Protagonist Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full PTGX income, balance, and cash tables.